Turn Therapeutics (TTRX) Interest Expenses (2024 - 2026)

Turn Therapeutics' Interest Expenses history runs 3 years deep, the most recent figure standing at $2.0 million for Q1 2026.

• On a quarterly basis, Interest Expenses rose 910.66% year-over-year to $2.0 million in Q1 2026; TTM through Mar 2026 was $2.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $8.1 million, up 108.3% from the prior year.
• Interest Expenses rose to $2.0 million in Q1 2026 per TTRX's latest filing, from $747679.0 in the prior quarter.
• Across five years, Interest Expenses topped out at $5.7 million in Q3 2025 and bottomed at $147107.0 in Q4 2024.
• The 3-year median for Interest Expenses is $553484.5 (2024), against an average of $1.5 million.
• Biggest YoY gain for Interest Expenses was 1477.39% in 2025; the steepest drop was 408.26% in 2025.
• Year by year, Interest Expenses stood at $147107.0 in 2024, then surged by 408.26% to $747679.0 in 2025, then jumped by 160.81% to $2.0 million in 2026.
• Per Business Quant, the three latest TTRX Interest Expenses figures stand at $2.0 million (Q1 2026), $747679.0 (Q4 2025), and $5.7 million (Q3 2025).